- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
U.S. Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
11
High return on equity, past performance and sound balance sheet.
11 companies
Corcept Therapeutics
Market Cap: US$5.9b
Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$56.01
7D
1.1%
1Y
141.1%
Medpace Holdings
Market Cap: US$9.9b
Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
MEDP
US$324.95
7D
-2.4%
1Y
-18.1%
Protagonist Therapeutics
Market Cap: US$3.4b
A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.
PTGX
US$54.78
7D
42.8%
1Y
89.0%
Exelixis
Market Cap: US$10.3b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$36.65
7D
-5.0%
1Y
59.5%
Agilent Technologies
Market Cap: US$34.5b
Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
A
US$121.18
7D
-4.4%
1Y
-17.8%
Catalyst Pharmaceuticals
Market Cap: US$2.6b
A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
CPRX
US$21.02
7D
-4.3%
1Y
30.8%
ADMA Biologics
Market Cap: US$4.4b
A biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$18.43
7D
8.3%
1Y
207.7%
Puma Biotechnology
Market Cap: US$164.7m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$3.32
7D
-5.4%
1Y
-33.6%
BioStem Technologies
Market Cap: US$179.0m
A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.
BSEM
US$10.75
7D
-11.7%
1Y
11.7%
Earth Science Tech
Market Cap: US$36.3m
Focuses on health and wellness industry.
ETST
US$0.12
7D
-7.0%
1Y
60.0%
Champions Oncology
Market Cap: US$126.4m
A technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States.
CSBR
US$9.23
7D
-7.1%
1Y
68.7%